ORANGE COUNTY, Calif., July 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC - News), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today second quarter and first half ended June 30, 2009 results. Total second quarter revenue was $756.7 million, down 5.2%, or flat in constant currency terms. On a constant currency basis, recurring revenue increased 7.7%, offset by the anticipated decline in cash instrument sales. Reported net earnings were $60.8 million, or $0.94 per fully diluted share. Adjusting for special items, net earnings were $63.9 million, or $0.99 per fully diluted share, an increase of 15.1% over prior year quarter (see “Non-GAAP Financial Measures” and “Reconciling Items to Non-GAAP Financial Measures”).
